(Q36709710)

English

Loiasis

scientific article published on December 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

Loiasis. (English)

1 reference

Europe PubMed Central

15 August 2017

Michel Boussinesq

1

object named as

Boussinesq M

1 reference

Europe PubMed Central

15 August 2017

publication date

1 December 2006

1 reference

Europe PubMed Central

15 August 2017

Annals of Tropical Medicine and Parasitology

1 reference

Europe PubMed Central

15 August 2017

100

1 reference

Europe PubMed Central

15 August 2017

715-731

1 reference

Europe PubMed Central

15 August 2017

8

1 reference

Europe PubMed Central

15 August 2017

Apheresis in the management of loiasis with high microfilariaemia and renal disease

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Transmission intensity affects both antigen-specific and nonspecific T-cell proliferative responses in Loa loa infection

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

IgG subclass recognition of Loa loa antigens and their correlation with clinical status in individuals from Gabon

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

The relationship between parasitological status and humoral responses to Loa loa antigens in the Mandrillus sphinx model after immunization with irradiated L3 and infection with normal L3.

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

New features on the moults and morphogenesis of the human filaria Loa loa by using rodent hosts consequences

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Clinical and laboratory features of patients with loiasis (Loa loa filariasis) in the U.K.

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Failed attempts at experimental transplantation and transmission of nocturnally-periodic simian Loa from monkey to man

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Loa loa infection without microfilaraemia

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Longitudinal survey of Loa loa filariasis in southern Cameroon: long-term stability and factors influencing individual microfilarial status.

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Genetic epidemiology of host predisposition microfilaraemia in human loiasis

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

The problem of loiasis in West Africa with special reference to recent investigations at Kumba in the British Cameroons and at Sapele in Southern Nigeria.

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

ADVANCES IN FILARIASIS ESPECIALLY CONCERNING PERIODICITY OF MICROFILARIAE.

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

The periodicity of microfilariae. XI. The effect of body temperature and other stimuli upon the cycles of Wuchereria bancrofti, Brugia malayi, B. ceylonensis and Dirofilaria repens.

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Serum immunoglobulin G4 antibodies to the recombinant antigen, Ll-SXP-1, are highly specific for Loa loa infection

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Hypothalamic-pituitary gonadal axis and immune response imbalance during chronic filarial infections

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Evidence against Wolbachia symbiosis in Loa loa

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Diethylcarbamazine prophylaxis for human loiasis. Results of a double-blind study

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Secondary collapsing glomerulopathy associated with Loa loa filariasis.

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Antibody-dependent cell-mediated immune reactions to Loa loa microfilariae in amicrofilaraemic subjects

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Effects of a 3-day regimen of albendazole (800 mg daily) on Loa loa microfilaraemia

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Encephalitis in loa-loa filariasis

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Identification and specificity of a 38 kDa Loa loa antigenic fraction in sera from high-microfilaraemic Gabonese patients

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Markers of Loa loa infection in permanent residents of a loiasis endemic area of Gabon

1 reference

https://api.crossref.org/works/10.1179%2F136485906X112194

21 January 2018

Identifiers

10.1179/136485906X112194

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36709710&oldid=1864578669"